Cargando…
Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug–Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results
Drug–drug interactions (DDIs) are a serious problem in the healthcare system, leading to excess healthcare utilization and costs. We conducted a second prospective randomized, controlled trial to further establish the real-world clinical utility of a novel assay that objectively identifies potential...
Autores principales: | Peabody, John, Schrecker, Joshua, Heltsley, Rebecca, Paculdo, David, de Belen, Enrico, Tamondong-Lachica, Diana, Acelajado, M. Czarina, Ouenes, Othman, Kennedy, Trina, Jeter, Elaine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307579/ https://www.ncbi.nlm.nih.gov/pubmed/34359349 http://dx.doi.org/10.3390/diagnostics11071266 |
Ejemplares similares
-
Drug-Drug Interaction Assessment and Identification in the Primary Care Setting
por: Peabody, John, et al.
Publicado: (2018) -
Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial
por: Peabody, John W., et al.
Publicado: (2017) -
Clinical Utility of Definitive Drug–Drug Interaction Testing in Primary Care
por: Peabody, John, et al.
Publicado: (2018) -
Improving Clinical Practice Using a Novel Engagement Approach: Measurement, Benchmarking and Feedback, A Longitudinal Study
por: Peabody, John W., et al.
Publicado: (2016) -
Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease
por: Peabody, John W, et al.
Publicado: (2023)